Reduction of T Lymphoma Cells and Immunological Invigoration in a Patient Concurrently Affected by Melanoma and Sezary Syndrome Treated With Nivolumab

Despite the recent availability of several new drugs in hemato-oncology, T-cell lymphomas are still incurable and PD-1 blockade could represent a therapeutic chance for selected patients affected by these malignancies, although further studies are required to understand the biological effects of ant...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Front Immunol
Main Authors: Narducci, Maria Grazia, Tosi, Anna, Frezzolini, Alessandra, Scala, Enrico, Passarelli, Francesca, Bonmassar, Laura, Monopoli, Alessandro, Accetturi, Maria Pina, Cantonetti, Maria, Antonini Cappellini, Gian Carlo, De Galitiis, Federica, Rosato, Antonio, Picozza, Mario, Russo, Giandomenico, D’Atri, Stefania
Formato: Artigo
Idioma:Inglês
Publicado: Frontiers Media S.A. 2020
Assuntos:
Immunology
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7544958/
https://ncbi.nlm.nih.gov/pubmed/33072126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2020.579894
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares